← Nano Nuclear Energy Inc. Common Stock overview

Nano Nuclear Energy Inc. Common Stock vs ASP Isotopes Inc. Common Stock: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Nano Nuclear Energy Inc. Common Stock (NNE)

Q3 2026
▲3▼1

Nano Nuclear Advances on Regulatory and Contract Wins, But No Revenue Yet

  • NRC Accepts KRONOS Construction Permit Application The U.S. Nuclear Regulatory Commission formally accepted Nano Nuclear's construction permit application for its KRONOS microreactor. This is a key regulatory step that could lead to a permit by late 2027. It boosts investor confidence because it shows real progress toward building a commercial reactor, though the reactor won't operate until the 2030s.

    This is a major regulatory milestone that directly advances the company's path to commercialization.

  • Air Force Research Contract for KRONOS MMR Nano Nuclear won a research contract with AFWERX, the Air Force's innovation arm, to study its KRONOS MMR energy system for military energy needs. The stock jumped about 10% on the news. While it's not a reactor sale, it adds credibility and potential future demand from the defense sector.

    This new contract provides external validation and opens a potential new customer channel.

  • Acquisition of Secured Transportation Services Nano Nuclear acquired Secured Transportation Services for $13 million, a profitable company that transports nuclear and radioactive materials. This gives Nano its first revenue stream and expands its nuclear ecosystem. It also leverages Nano's strong cash position of $569 million.

    This acquisition provides immediate revenue and strategic vertical integration.

  • Still Pre-Revenue, Stock Down 70% from High An article highlighted that Nano Nuclear, like Oklo and NuScale, has no revenue and is pre-commercial. The stock is about 70% below its 52-week high. While the company has cash, the lack of sales and long timeline to commercialization weigh on the stock.

    This points out the key risk: no revenue and a beaten-down share price.

July 2026
▲3▼1

Nano Nuclear Advances on Regulatory and Contract Wins, But No Revenue Yet

  • NRC Accepts KRONOS Construction Permit Application The U.S. Nuclear Regulatory Commission formally accepted Nano Nuclear's construction permit application for its KRONOS microreactor. This is a key regulatory step that could lead to a permit by late 2027. It boosts investor confidence because it shows real progress toward building a commercial reactor, though the reactor won't operate until the 2030s.

    This is a major regulatory milestone that directly advances the company's path to commercialization.

  • Air Force Research Contract for KRONOS MMR Nano Nuclear won a research contract with AFWERX, the Air Force's innovation arm, to study its KRONOS MMR energy system for military energy needs. The stock jumped about 10% on the news. While it's not a reactor sale, it adds credibility and potential future demand from the defense sector.

    This new contract provides external validation and opens a potential new customer channel.

  • Acquisition of Secured Transportation Services Nano Nuclear acquired Secured Transportation Services for $13 million, a profitable company that transports nuclear and radioactive materials. This gives Nano its first revenue stream and expands its nuclear ecosystem. It also leverages Nano's strong cash position of $569 million.

    This acquisition provides immediate revenue and strategic vertical integration.

  • Still Pre-Revenue, Stock Down 70% from High An article highlighted that Nano Nuclear, like Oklo and NuScale, has no revenue and is pre-commercial. The stock is about 70% below its 52-week high. While the company has cash, the lack of sales and long timeline to commercialization weigh on the stock.

    This points out the key risk: no revenue and a beaten-down share price.

Latest
▲3▼1

Nano Nuclear Advances on Regulatory and Contract Wins, But No Revenue Yet

  • NRC Accepts KRONOS Construction Permit Application The U.S. Nuclear Regulatory Commission formally accepted Nano Nuclear's construction permit application for its KRONOS microreactor. This is a key regulatory step that could lead to a permit by late 2027. It boosts investor confidence because it shows real progress toward building a commercial reactor, though the reactor won't operate until the 2030s.

    This is a major regulatory milestone that directly advances the company's path to commercialization.

  • Air Force Research Contract for KRONOS MMR Nano Nuclear won a research contract with AFWERX, the Air Force's innovation arm, to study its KRONOS MMR energy system for military energy needs. The stock jumped about 10% on the news. While it's not a reactor sale, it adds credibility and potential future demand from the defense sector.

    This new contract provides external validation and opens a potential new customer channel.

  • Acquisition of Secured Transportation Services Nano Nuclear acquired Secured Transportation Services for $13 million, a profitable company that transports nuclear and radioactive materials. This gives Nano its first revenue stream and expands its nuclear ecosystem. It also leverages Nano's strong cash position of $569 million.

    This acquisition provides immediate revenue and strategic vertical integration.

  • Still Pre-Revenue, Stock Down 70% from High An article highlighted that Nano Nuclear, like Oklo and NuScale, has no revenue and is pre-commercial. The stock is about 70% below its 52-week high. While the company has cash, the lack of sales and long timeline to commercialization weigh on the stock.

    This points out the key risk: no revenue and a beaten-down share price.

ASP Isotopes Inc. Common Stock (ASPI)